News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2023 Caitlin E. Cox December 28, 2023
News Daily News FDA Approves Paradise Renal Denervation System: What Comes Next? Todd Neale November 08, 2023
News Daily News Most Patient-Reported Outcome Measures in CVD Fall Short L.A. McKeown September 23, 2022
News Daily News Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles Michael O'Riordan May 12, 2021
News Daily News FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients Todd Neale October 12, 2018